Return to search

Freenome lands $270m Series C

South San Francisco-based Freenome, a provider of a multiomics platform for early cancer detection, has raised $270 million in Series C funding.

South San Francisco-based Freenome, a provider of a multiomics platform for early cancer detection, has raised $270 million in Series C funding. Bain Capital Life Sciences and Perceptive Advisors led the round.

Source: Press Release